Cancer

March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.

By VUMC News and Communications
February 25, 2016

Chemo better option following pancreatic cancer surgery: study

A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.

By VUMC News and Communications
February 18, 2016

Combining treatments for melanoma

Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients.

By Leigh MacMillan
February 18, 2016

Study explores less invasive way to monitor colorectal cancer

Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.

By VUMC News and Communications
February 11, 2016

Transplant Center initiative seeks to boost cancer education

Lindsay Ramsey Smith, MSN, R.N., a quality consultant for the Vanderbilt Transplant Center (VTC), recently uncovered some interesting data that sparked a center-wide improvement project.

By Jessica Pasley
February 11, 2016

Annual Pink Out women’s basketball game set for Feb. 14

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer.

By VUMC News and Communications
February 11, 2016

Study identifies potential colon cancer biomarker

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.
By Bill Snyder
February 10, 2016

Overcoming lung cancer drug resistance

Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.
By Marilyn Holt
February 4, 2016

Prostate cancer survivors’ risk of heart disease studied

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.
By Kathy Whitney
February 4, 2016

VICC joins other major cancer centers in HPV vaccine campaign

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.
By VUMC News and Communications
January 27, 2016

Study identifies new culprit in lung cancer development

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.
By Leigh MacMillan
January 21, 2016

Medical staff, theater join forces to help cancer patient see ‘Star Wars’

A Vanderbilt patient who has battled leukemia for nearly five years was granted a private screening of “Star Wars: The Force Awakens,” thanks to her medical providers and a local movie theater.
By VUMC News and Communications
January 21, 2016

Lovly lands cancer research grant from V Foundation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.
By VUMC News and Communications
1 … 43 44 45 46 47 … 69